For a second year now, on Friday April 7th, the Toronto Chapter of Aging 2.0 is holding its Global Start Up Search, a local pitch event that will award an entrepreneur for the best “aging-focused start-up”. This pitch event in the only Canadian city in the Aging 2.0 Network is one link in the chain of a very active, well- connected and funded market for aging and technology. All of their regional pitch events will lead to the big finale in November at the Aging 2.0 Optimize event in San Francisco.
Last year the winner was Winterlight Labs for their development of a tech-based solution that “monitors cognitive health through speech recognition”. Often you wonder how successful some of these tech start-ups are over the long term, and it is good to see how Winterlight, as an example, has matured over the last two years, out of their research work in 2015 on dementia and Alzheimer’s Disease, to the contest phase to the funding phase.
Following a winner, as of January 2017, Winterlight has just received a first portion of $500K in seed funding from a life sciences investment company, Novatio Ventures. But the innovation extended family trail doesn’t end there as Winterlight will also be joining Johnson & Johnson’s JLABS in Toronto, another science based innovation centre.
All of this news is another indication of how big this marriage of science and technology is becoming, in what I like to call the emerging aging & longevity market. Of course, all of this innovation and joint venturing in this particular category gets largely lost in the wider sweeping dialogue about Canada’s 2017 “Innovation Economy” drive.
However, that is why I keep following this space in the market and present it in as many ways as possible, including this Planet Longevity blog. We do need to celebrate the start-up winners who prove their own longevity. This year there are six start-ups featured in the Toronto pitch event.
Let’s see who comes out on top, but after poking around their stories (at least as told in their web narratives), the one story that appealed to me the most is ACEAGE. There are two angles to this tech device: the first that schedules medication and provides a component for caregiver monitoring, and the second that facilitates data collection for clinical trials. Welcome to another aid instrument in the age of telecare and telemedicine.
Can’t hardly wait for this news while another major contest is in its final stage – the Stanford Center on Longevity: Design Challenge. Maybe there is something in the April air to come – Spring Innovation Fever!